World's Largest Study on ACE Inhibitors, ARBs Shows No Increased Patient Risk of COVID-19 Diagnosis, Complications - Columbia DBMI
ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking | Critical Care | Full Text
Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence? | Cardiovascular Diabetology | Full Text
NKF KDOQI Guidelines
ACEIs and ARBs and Their Correlation with COVID-19: A Review | IDR
ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine
Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population | Scientific Reports
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
RACGP - ACEIs for cardiovascular risk reduction – have we taken our eye off the ball?
Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19 | SpringerLink
Aug 4, 2014: How does naloxone work to reverse the effects of ACE inhibitor toxicity? | Tennessee Poison Center | FREE 24/7 Poison Help Hotline 800.222.1222
Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left Ventricular Assist Devices - ScienceDirect
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
FDA Advise-ERR: Concomitant use of Entresto and ACE inhibitors Can Lead to Serious Outcomes | Institute For Safe Medication Practices
Angiotensin Receptor Blockers versus ACE Inhibitors: Prevention of Death and Myocardial Infarction in High-Risk Populations - Benjamin J Epstein, John G Gums, 2005
Which Inhibitor of the Renin–Angiotensin System Should Be Used in Chronic Heart Failure and Acute Myocardial Infarction? | Circulation
Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension? | SpringerLink
Should Angiotensin II Receptor Blockers and Statins Be Combined? | Circulation
There's just been AKI. So what do we do with the ACEi/ARB? — NephJC
Choice of drug therapy in primary (essential) hypertension - UpToDate
COVID-19 and Use of Drugs Targeting the Renin-Angiotensin-System - American College of Cardiology
ARB might be superior to ACEI for treatment of hypertensive COVID‐19 patients - Zhao - 2021 - Journal of Cellular and Molecular Medicine - Wiley Online Library
Understanding the renin–angiotensin–aldosterone–SARS-CoV axis: a comprehensive review | European Respiratory Society
Cross-Reactivity of ACE Inhibitor–Induced Angioedema with ARBs
A practical guide to antiproteinuric drugs in dogs
Molecules | Free Full-Text | From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Clinical Experience With Angiotensin Receptor Blockers
